Daiichi Sankyo’s API Plant at Fukushima to Remain Offline Until September

Pharmaceutical company Daiichi Sankyo (Tokyo) says its Onahama plant in Fukushima prefecture, which produces active pharmaceutical ingredients (API), including pravastatin and olmesartan, is expected to restart production in September 2011. The plant was partly damaged by the earthquake that struck Japan on March 11, and has been offline since then. “Work on the restoration of facilities and equipment used in the manufacture of these products is already underway, with September of this year as a goal for the start of production,” the company says. The...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers